Risk factors for illness absence due to musculoskeletal disorders in a 4-year prospective study of a petroleum-manufacturing population.

J Occup Environ Med

Shell Oil Company, Shell Health, One Shell Plaza, Houston, TX 77252–2463, USA.

Published: April 2011

Objectives: To quantify risk factors for nonoccupational absence from musculoskeletal disorders (MSD) among petroleum-manufacturing employees.

Methods: We conducted a 4-year follow-up study including 860 employees with an MSD illness absence of 4 days or longer and 5691 employees with no MSD absence. Odds ratios were calculated using logistic regression.

Results: Risk of MSD absence from low back and non-low back disorders was significantly associated with physically demanding job, overweight/obesity, prior absence from MSD, and absence from cardiovascular, respiratory, or mental illness, or accidents during the study period. Smoking also increased risk of low back disorders.

Conclusions: Results suggest it is possible to reduce the impact of MSD through integrated safety prevention and health promotion programs including traditional elements of job factor evaluation, training, and ergonomics, but also health counseling and support for weight reduction, smoking cessation, and personal fitness programs.

Download full-text PDF

Source
http://dx.doi.org/10.1097/JOM.0b013e3182128b12DOI Listing

Publication Analysis

Top Keywords

msd absence
12
risk factors
8
illness absence
8
absence musculoskeletal
8
musculoskeletal disorders
8
employees msd
8
absence
7
msd
6
risk
4
factors illness
4

Similar Publications

Bone marrow transplantation reverses metabolic alterations in multiple sulfatase deficiency: a case series.

Commun Med (Lond)

January 2025

Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.

Background: Multiple sulfatase deficiency (MSD) is an exceptionally rare neurodegenerative disorder due to the absence or deficiency of 17 known cellular sulfatases. The activation of all these cellular sulfatases is dependent on the presence of the formylglycine-generating enzyme, which is encoded by the SUMF1 gene. Disease-causing homozygous or compound heterozygous variants in SUMF1 result in MSD.

View Article and Find Full Text PDF

Electrotherapy as treatment for chemotherapy-induced peripheral neuropathy - a randomized controlled trial.

Front Neurol

December 2024

IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.

Background: Electrotherapy has been investigated in chronic pain and diabetic peripheral neuropathy, however prospective trials in patients with chemotherapy-induced peripheral neuropathy (CIPN) are scarce.

Methods: Fifty-one patients with CIPN ≥ grade 1 subsequent to receiving platinum- and/or taxane-based chemotherapy types were randomized to 8 weeks of high tone external muscle stimulation (HTEMS) or transcutaneous electrical nerve stimulation (TENS). The primary outcome were changes in the EORTC-QLQ-CIPN20 questionnaire.

View Article and Find Full Text PDF

Objectives: To evaluate (1) the association between nailfold capillaroscopy pattern and 5-year risk for incident interstitial lung disease and (2) the association between transition in nailfold capillaroscopy pattern and risk of incident interstitial lung disease.

Methods: Data of adult patients from the EUSTAR database fulfilling the ACR-EULAR criteria with a disease duration ⩽5 years, having a scleroderma pattern at nailfold capillaroscopy with high-resolution computed tomography confirmed absence of interstitial lung disease (i.e.

View Article and Find Full Text PDF

Background And Aims: Presence of active hepatitis C virus (HCV) infection may influence the outcome of patients treated for hepatocellular carcinoma (HCC), although this issue has never been adequately assessed in a large series of patients. The aim of this study was to evaluate whether the presence of active HCV affects the survival of patients treated for HCC.

Methods: This study assessed the outcome of 3123 anti-HCV-positive patients with HCC, subdivided according to the presence of active HCV infection or previous sustained virological response (SVR).

View Article and Find Full Text PDF

Double Deletion of EP402R and EP153R in the Attenuated Lv17/WB/Rie1 African Swine Fever Virus (ASFV) Enhances Safety, Provides DIVA Compatibility, and Confers Complete Protection Against a Genotype II Virulent Strain.

Vaccines (Basel)

December 2024

European Union Reference Laboratory for African Swine Fever (EURL), Centro de Investigación en Sanidad Animal (CISA), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Consejo Superior de Investigaciones Científicas (CSIC), Valdeolmos, 28130 Madrid, Spain.

African swine fever virus (ASFV) is a devastating disease affecting domestic and wild suids and causing significant economic losses in the global pig industry. Attenuated modified live virus (MLV) vaccines are the most promising approaches for vaccine development. This study aimed to evaluate the safety and efficacy of four recombinant ASFV genotype II strains, derived from the non-hemadsorbing (non-HAD) attenuated isolate Lv17/WB/Rie1, through the single or simultaneous deletion of virulence-associated genes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!